Strategic Outsourcing Often Means Combining CROs

By Kate Hammeke, director of marketing intelligence, Nice Insight

If you’re in the business of drug development as an innovator, chances are outsourcing has become part of your strategy. Engaging outside firms to complete one or more of the steps necessary to bring a new medicine to market has been proven to add value to the process by reducing fixed costs, shortening timelines and offering access to niche expertise. With outsourcing becoming so integral to drug development strategy, the term “strategic” can be applied to almost any method of engaging outside providers, whether it is for a single element of the process or multiple steps along the way.